Intellia Therapeutics Inc buy Citizens Jmp
Start price
06.10.25
/
50%
€17.99
Target price
06.10.26
€28.15
Performance (%)
-38.13%
Price
24.03.26
€11.13
Summary
This prediction is currently active. The BUY prediction by Citizens_Jmp for Intellia Therapeutics Inc is performing very badly with a performance of -38.13%. This prediction currently runs until 06.10.26. The prediction end date can be changed by Citizens_Jmp at any time. Citizens_Jmp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.872% | -4.872% |
| iShares Core DAX® | -3,64 % | -8,78 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % |
| iShares S&P 500 | -2,39 % | -2,78 % |
Comments by Citizens_Jmp for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Citizens Jmp from a "market perform" rating to an "outperform" rating. They now have a $33.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat